UnitedHealth Group Stock Performance
UnitedHealth Group shares traded at $379.30, reflecting a daily decline of approximately 1.02% per SID market data. Over the trailing one-month period, the stock has fallen 5.63%, while the three-month return shows a steeper 12.64% decline. Despite these near-term pullbacks, UNH has posted a 14.21% gain over the past twelve months. The stock currently trades below its 50-day moving average of $390.02 but remains above the 200-day moving average of $350.86, according to SID market data, suggesting a mixed technical posture. The 14-day relative strength index stands at 43.7, placing UNH in neutral territory but leaning toward oversold conditions. Average daily trading volume is approximately 8.77 million shares. The stock carries a beta of 0.432, indicating significantly lower volatility relative to the broader market, consistent with the defensive characteristics of the healthcare sector.
UnitedHealth Group Valuation Analysis
UnitedHealth Group carries a market capitalization of approximately $305 billion, positioning it as one of the largest companies in the healthcare sector, according to SID market data. The stock trades at a price-to-earnings ratio of 17.38, which remains moderate relative to large-cap peers and broadly in line with healthcare sector averages. The price-to-book ratio stands at 3.19, per SEC filings, reflecting the market's premium for UNH's franchise value and diversified business model spanning insurance and Optum services. The company offers a dividend yield of approximately 2.59%, providing income alongside capital appreciation potential. Notably, the PEG ratio is negative at -1.02, driven by adjustments in forward growth estimates that warrant monitoring. Taken together, UNH's valuation metrics suggest the stock is priced at a level that reflects its scale and earnings power while incorporating recent headwinds that have compressed the multiple from prior highs.
Smart Money Activity for UNH
UnitedHealth Group's composite smart money score stands at 40 out of 100 with a neutral signal, according to SID market data. The institutional component scores a perfect 25 out of 25, indicating robust and sustained interest from major fund managers as reflected in 13F institutional filings. In contrast, the insider trading component registers at 0 out of 25 despite notable recent activity — SEC Form 4 filings reveal 20 insider transactions over the past 90 days, all of which were purchases with zero sells recorded. This unanimous buying pattern among corporate insiders suggests internal confidence in the company's forward trajectory, even as the composite score remains subdued. The dark pool activity score of 8.5 out of 25 indicates moderate off-exchange institutional trading, while the congressional trading component sits at 6.4 out of 25. The divergence between strong insider buying and the overall neutral score reflects mixed signals across different smart money categories, requiring investors to weigh each component independently.
UnitedHealth Group Earnings Outlook
UnitedHealth Group's most recent quarterly earnings report delivered strong results, with actual earnings per share of $7.23 compared to analyst estimates of $6.56, representing a positive surprise of $0.67 or approximately 10.2%, according to company earnings reports. The prior quarter also exceeded expectations, posting $6.38 per share against estimates of $4.85, a substantial $1.53 beat representing a 31.5% upside surprise. These consecutive earnings beats underscore operational strength across UNH's insurance and Optum segments. Looking ahead, analyst estimates project earnings of $4.14 per share for each of the next two reporting periods, per consensus data. The significant step-down in estimated earnings relative to recent actuals reflects typical seasonality in the managed care business. Investors will monitor whether UNH can sustain its pattern of exceeding expectations when the next results are reported.
Wall Street Analyst Ratings for UNH
Wall Street analyst sentiment on UnitedHealth Group remains predominantly constructive, according to SID consensus data. Among the most recent ratings, four of five covering analysts maintain bullish designations. JP Morgan reaffirmed its Overweight rating on July 21, while Barclays reiterated Overweight on July 20, per Wall Street analyst reports. Mizuho maintained its Outperform rating on July 21, and RBC Capital reaffirmed Outperform on July 17, collectively reflecting confidence in UNH's fundamental positioning. The sole exception is TD Cowen, which reiterated a Hold rating on October 9, representing the most cautious stance among recent coverage updates. Notably, none of the five analysts downgraded their ratings, with each maintaining prior assessments unchanged. The clustering of reaffirmations around the July earnings period suggests the strong quarterly results reinforced existing bullish theses. The consensus leans toward continued outperformance, with 80% of recent ratings carrying buy-equivalent designations for UNH shares.
